SureTrader SureTrader
Home > Boards > US OTC > Cannabis >

Cannabix Technologies Inc. (BLOZF)

Add BLOZF Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, shell3, smoki, ILuvblo2, FreezeThese, SO75
Search This Board:
Last Post: 10/24/2016 6:10:22 PM - Followers: 168 - Board type: Free - Posts Today: 11

Cannabix Technologies Inc. (formerly West Point Resources Inc.) (CSE: BLO, US OTC: BLOZF,
Frankfurt: 8CT:FRA) is a Vancouver, B.C. based technology company.o

Cannabix Technologies has the exclusive North American license for the Cannabix Marijuana Breathalyzer from Cannabix Breathalyzer Inc.
Cannabix Technologies has Rights to "
Partial ovoidal FAIMS electrode - Patent 8,237,118" from the University of Florida
for the WORLD for CONTROLLED SUBSTANCE for 10 Years after 1st Product sold

What is FAIMS-MS?
40 Minute Video with Dr Yost

Cannabix Technologies' common shares trade on the Canadian Securities Exchange and US OTC Pinksheets and European Frankfurt Exchange.
Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana.  Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions.  Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing

CSE:BLO          Pinksheets: BLOZF  Frankfurt: 8CT:FRA

Common Shares

Issued and Outstanding
78,287,942(as of October 5, 2016)

Warrants Issued but not Exerscised  13,489,159
Options Issued but not Exercised  6,661,000
IF a Patent is Issued another 5M Shares

Fully Diluted w/Warrants, w/Options  and w/Patent issued 103,437,601

Cannabix Corporate Video

Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc.  Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development.  Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD.,  Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products.  Dr.  Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.

Dr. Bruce Goldberger, PhD,  Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida.  Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.

Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Jared Boock Ph.D, Principal investigator
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.

Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).

Rav Mlait, MBA – CEO, Director
.Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.

Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.

Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge. 

Andrew Davies,  Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016).  Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine. 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
BLOZF News: Cannabix Technologies Develops Beta 2.0 Marijuana Breathalyzer 10/19/2016 08:45:00 AM
BLOZF News: Cannabix Technologies is Well-Positioned to Capitalize on Anticipated Marijuana Legalization in Canada and United States 10/04/2016 09:04:58 AM
BLOZF News: Justin Timberlake’s Aftermaster, Inc. (OTCQB: AFTM) Begins Production - Partners with ON Semiconductor (NADAQ: ON) 10/04/2016 07:00:00 AM
#14848  Sticky Note Know what you own - 78M OS with shell3 10/21/16 11:46:26 AM
#14726  Sticky Note Cannabix Technologies Develops Beta 2.0 Marijuana Breathalyzer FreezeThese 10/19/16 09:40:13 AM
#14253  Sticky Note Cannabix Oct 4th Video Release - BETA 2.0 shell3 10/04/16 11:38:16 PM
#14905   only few weeks left on cheapies, hope everyone rjp15 10/24/16 06:10:22 PM
#14904   2.9M Volume continues shell3 10/24/16 04:37:08 PM
#14903   Share Volume over 2M shares already shell3 10/24/16 01:37:02 PM
#14902   Yep, >150% increase over the past 30 days really sucks... euroconversions 10/24/16 12:17:42 PM
#14901   wow,worst MJ stock - This POS is lagging stockzoom 10/24/16 12:00:59 PM
#14900   Doing well with my two marijuana breathalyzer Stocks! 3DYOGI 10/24/16 10:37:15 AM
#14899   21k on bid at $0.44 ... somebody's betting FreezeThese 10/24/16 09:38:53 AM
#14898   $0.42/$0.449 FreezeThese 10/24/16 09:30:11 AM
#14897   The decision to have separate licenses may not mfascuba 10/24/16 08:31:20 AM
#14896   I agree they also were able to pool ILuvblo2 10/24/16 07:57:08 AM
#14894   Double dipping allegations toker 10/23/16 11:42:08 PM
#14893   Looks Like Mlait is moving into another deal toker 10/23/16 08:28:54 PM
#14892   Nice find UCPARADISE. It's very exciting watching it SO75 10/23/16 05:59:48 PM
#14891 standing-by on th he Lauch pad 3-4 smoki 10/23/16 04:05:50 PM
#14890   By spring testing completed and off for approval UCParadise 10/23/16 04:02:17 PM
#14889   Nice find UCParadise! Another interesting thing Kal mentioned is euroconversions 10/23/16 04:02:07 PM
#14888   My opinion is just that, it is my geodcan 10/23/16 03:47:34 PM
#14887   Thanks, I just listened to it, 1st shell3 10/23/16 03:44:09 PM
#14886   Kal says it in this interview from 10/13/16. UCParadise 10/23/16 03:33:12 PM
#14885   NICE...UCParadise, Kal saying going to testing in rjp15 10/23/16 03:05:38 PM
#14884   You have a Link to share of the shell3 10/23/16 02:21:47 PM
#14883   Looks like Beta 2.0 is the size of UCParadise 10/23/16 11:47:50 AM
#14882   He's the only man that can wear his shell3 10/23/16 11:43:37 AM
#14881 Interview w UCParadise 10/23/16 11:05:29 AM
#14880   geodcan - Let's take your quest/ion to litigate AMG 10/23/16 03:00:06 AM
#14879   Hey....plenty of news was out there at least smoki 10/22/16 11:57:36 PM
#14878   geodcan: Same vacuum cleaner with a different nozzle for AMG 10/22/16 06:09:11 PM
#14877   Agree buy BTH rjp15 10/22/16 06:00:56 PM
#14876   Sorry NO SCAM HERE...its about the day traders...get real rjp15 10/22/16 05:59:16 PM
#14875   NO SCAM HERE rjp15 10/22/16 05:57:12 PM
#14874   GREAT stuff, shell...TY rjp15 10/22/16 05:53:58 PM
#14873   I believe Cannabix requires a Vote of Outstanding shell3 10/22/16 10:37:52 AM
#14872   Hope your still following, I understand your shell3 10/22/16 10:10:49 AM
#14871   Is it true that management can release unlimited rabrok88 10/22/16 10:05:15 AM
#14869   I think you're right on. The only "pump dilligence 10/22/16 01:28:03 AM
#14868   Court certification only for BLO. Law exists. SO75 10/21/16 08:52:22 PM
#14866   Lol, "they" haven't re purposed "our" technology. They medchem 10/21/16 08:48:32 PM
#14865   Same vacuum cleaner with a different nozzle for geodcan 10/21/16 08:46:55 PM
#14864 SO75 10/21/16 08:32:07 PM
#14862   True - it wouldn't be a good idea medchem 10/21/16 05:45:33 PM
#14861   Also fair. I agree. And back to my medchem 10/21/16 05:40:45 PM
#14860   attuned to the market makers pumping and dumping. lucky,mydog 10/21/16 05:39:12 PM
#14859   Fair. My point remains, that managements timing of medchem 10/21/16 05:35:42 PM
#14858   You're being widely presumptuous to assume that "they" DiamondInTheRough 10/21/16 04:03:23 PM
#14857   Some serious manipulation has occurred as of late, medchem 10/21/16 04:01:23 PM
#14856   I must disagree. This could be a scam. medchem 10/21/16 03:58:54 PM
#14855   PUMP and DUMP pattern is more like it. medchem 10/21/16 03:56:16 PM
#14854   There won't be any good news coming for medchem 10/21/16 03:55:10 PM
#14853   You should really do some due diligence and geodcan 10/21/16 03:22:15 PM
#14852   Even if it’s legal, some employers may keep shell3 10/21/16 02:18:50 PM